Jeffrey A. Ross

2.6k total citations
124 papers, 1.7k citations indexed

About

Jeffrey A. Ross is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jeffrey A. Ross has authored 124 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 37 papers in Cancer Research and 17 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jeffrey A. Ross's work include Carcinogens and Genotoxicity Assessment (34 papers), DNA Repair Mechanisms (19 papers) and DNA and Nucleic Acid Chemistry (14 papers). Jeffrey A. Ross is often cited by papers focused on Carcinogens and Genotoxicity Assessment (34 papers), DNA Repair Mechanisms (19 papers) and DNA and Nucleic Acid Chemistry (14 papers). Jeffrey A. Ross collaborates with scholars based in United States, United Kingdom and Australia. Jeffrey A. Ross's co-authors include Stephen Nesnow, Garret B. Nelson, Gary D. Stoner, Anthony J. Galati, Marc J. Mass, M J Mass, Ramesh C. Gupta, Stephanie A. Leavitt, Edward M. Scolnick and Wade P. Parks and has published in prestigious journals such as Nucleic Acids Research, Contemporary Sociology A Journal of Reviews and PLoS ONE.

In The Last Decade

Jeffrey A. Ross

116 papers receiving 1.6k citations

Peers

Jeffrey A. Ross
Richard D. Irons United States
Charles W. Riggs United States
Matthew S. Bogdanffy United States
William A. Toscano United States
Joseph R. Landolph United States
William Lijinsky United States
Jimmie B. Vaught United States
Jeffrey C. Theiss United States
David P. Lovell United Kingdom
Richard D. Irons United States
Jeffrey A. Ross
Citations per year, relative to Jeffrey A. Ross Jeffrey A. Ross (= 1×) peers Richard D. Irons

Countries citing papers authored by Jeffrey A. Ross

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Ross more than expected).

Fields of papers citing papers by Jeffrey A. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Ross. The network helps show where Jeffrey A. Ross may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Ross. A scholar is included among the top collaborators of Jeffrey A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Ross. Jeffrey A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mishra, Ram Kinker, et al.. (2022). The Application of Digital Frailty Screening to Triage Nonhealing and Complex Wounds. Journal of Diabetes Science and Technology. 18(2). 389–396. 8 indexed citations
3.
Gadgeel, Shirish M., Adrienne Johnson, Leora Horn, et al.. (2017). P3.02c-024 Detection of Novel Activating FGFR Rearrangements, Truncations, and Splice Site Alterations in NSCLC by Comprehensive Genomic Profiling. Journal of Thoracic Oncology. 12(1). S1286–S1286. 1 indexed citations
4.
Ikeda, Sadakatsu, Laurie M. Gay, Dean C. Pavlick, et al.. (2017). Comprehensive Genomic Profiling (CGP) of 114,200 advanced cancers identifies recurrent Kinase Domain Duplications (KDD) and novel oncogenic fusions in diverse tumor types. Annals of Oncology. 28. x1–x1. 3 indexed citations
5.
Ross, Jeffrey A. & Stephanie A. Leavitt. (2010). Analysis of the mutations induced by conazole fungicides in vivo. Mutagenesis. 25(3). 231–234. 12 indexed citations
6.
Ross, Jeffrey A., et al.. (2009). K‐Ras mutant fraction in A/J mouse lung increases as a function of benzo[a]pyrene dose. Environmental and Molecular Mutagenesis. 51(2). 146–155. 23 indexed citations
7.
Ross, Jeffrey A., Tanya Moore, & Stephanie A. Leavitt. (2008). In vivo mutagenicity of conazole fungicides correlates with tumorigenicity. Mutagenesis. 24(2). 149–152. 26 indexed citations
8.
Leavitt, Stephanie A., Michael H. George, Tanya Moore, & Jeffrey A. Ross. (2008). Mutations induced by benzo[a]pyrene and dibenzo[a,l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts. Mutagenesis. 23(6). 445–450. 24 indexed citations
9.
Banasiewicz, Marzena, Garret B. Nelson, Adam Swank, et al.. (2004). Identification and quantitation of benzo[a]pyrene-derived DNA adducts formed at low adduction level in mice lung tissue. Analytical Biochemistry. 334(2). 390–400. 9 indexed citations
10.
Nesnow, Stephen, Christine Davis, Garret B. Nelson, et al.. (2002). Comparison of the genotoxic activities of the K-region dihydrodiol of benzo[a]pyrene with benzo[a]pyrene in mammalian cells: morphological cell transformation; DNA damage; and stable covalent DNA adducts. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 521(1-2). 91–102. 16 indexed citations
11.
Benane, S. G., Garret B. Nelson, Jeffrey A. Ross, & Carl F. Blackman. (1999). Benzo[A]Pyrene and Dibenzo[A, L]Pyrene do not Alter gap Junction Communication in Rat Liver Epithelial Cells. Polycyclic aromatic compounds. 17(1-4). 53–62. 1 indexed citations
12.
Ansell, I. D., et al.. (1998). Sphingosine and sphinganine levels in human mesothelial cells in vitro as a potential index of signal transduction pathways impacted by microbes and osmolality.. PubMed. 14. 158–63. 1 indexed citations
13.
Mass, Marc J., Amal Abu‐Shakra, Barbara C. Roop, et al.. (1996). Benzo[b]fluoranthene: tumorigenicity in strain A/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene. Carcinogenesis. 17(8). 1701–1704. 25 indexed citations
14.
Nesnow, Stephen, Jeffrey A. Ross, Gary D. Stoner, & Marc J. Mass. (1995). Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology. 105(2-3). 403–413. 60 indexed citations
15.
You, Liang, Dian Wang, Anthony J. Galati, et al.. (1994). Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung. Carcinogenesis. 15(11). 2613–2618. 21 indexed citations
16.
Middleton, Peter G., Shannon C. Miller, Jeffrey A. Ross, C. M. Steel, & Keith Guy. (1992). Insertion of SMRV‐H viral DNA at the c‐myc gene locus of a BL cell line and presence in established cell lines. International Journal of Cancer. 52(3). 451–454. 15 indexed citations
17.
Ross, Jeffrey A., Garret B. Nelson, Andrew D. Kligerman, et al.. (1992). DNA adducts and induction of sister chromatid exchanges in the rat following benzo[b]fluoranthene administration. Carcinogenesis. 13(10). 1731–1734. 10 indexed citations
18.
Nesnow, Stephen, et al.. (1989). DNA adduct formation, metabolism, and morphological transforming activity of aceanthrylene in C3H10T1/2CL8 cells. Mutation Research/Genetic Toxicology. 222(3). 223–235. 14 indexed citations
19.
Brualdi, Richard A. & Jeffrey A. Ross. (1980). On Ryser's maximum term rank formula. Linear Algebra and its Applications. 29. 33–38. 13 indexed citations
20.
Ross, Jeffrey A., et al.. (1972). Findings from family planning research.. PubMed. 12. 1–47. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026